GeminIQ

ZTS

Zoetis Inc.
—

Company Information

Company Name
Zoetis Inc.
CIK
CIK0001555280
Category
Large accelerated filer
Ticker: Exchange
ZTS: NYSE
Fiscal Year End
December 31
Owner Organization
03 Life Sciences
SIC
2834
SIC Description
Pharmaceutical Preparations
Ticker
ZTS

SEC filing data through

Insider Sentiment

Last purchase
2026-05-13
Last sale
2026-02-17
Shares purchased (TTM)
11,650
Shares sold (TTM)
20,652
Buy ratio (TTM)36.1%

Institutional Sentiment

As of
2026-06-30
Institutional shares owned
387,530,398
Shares outstanding
417,600,000
Ownership
92.80%
+2.73% Y/Y

Earnings Market Reaction

Filing date
2026-08-06
Price on filing date
—
1-month reaction
0.09%
3-month reaction
…
Drift continued6/11 (55%)
Faded / reversed5/11 (45%)
Export data

Balance Sheet

Values in millions ($)
Line item2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-30Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnTrend
Assets
Cash And Cash Equivalents At Carrying Value1,4761,9412,3122,0841,4351,7211,9871,7141,5741,9752,0411,754
Short Term Investments200-----------
Accounts Receivable Net Current1,5711,5061,5901,5411,5401,3611,3161,4111,3831,2931,3041,257
Inventory Net2,5742,5502,4302,4652,4392,3652,3062,4162,4522,6512,5642,744
Assets Of Disposal Group Including Discontinued Operation-------314326---
Other Assets Current535477436493509430377427467440434467
Assets Current6,3566,4746,7686,5835,9235,8775,9866,2826,2026,3596,3436,222
Property Plant And Equipment Net3,7563,7193,6813,6003,5373,4413,3913,2983,2003,2513,2043,092
Operating Lease Right Of Use Asset275282288292302220219223222225230226
Goodwill2,7712,7782,7672,7642,7582,7162,7242,7442,7392,7592,7592,762
Intangible Assets Net Excluding Goodwill9189599981,0401,0751,0821,1271,1861,2261,2951,3381,398
Deferred Income Tax Assets Net617591637587617530540409366232206190
Other Assets Noncurrent384351328293267232250215210227206216
Assets15,07715,15415,46715,15914,47914,09814,23714,35714,16514,34814,28614,106
Liabilities And Stockholders Equity
Long Term Debt Current--001,3501,3501,350---00
Short Term Borrowings------0002432
Accounts Payable Current452507487410508420433404420405411388
Dividends Payable Current221224232022222422401971981980
Accrued Liabilities Current--852---746---683-
Other Accrued Liabilities Current856751-809770772-725704691-693
Employee Related Liabilities Current269239410337293291441335276272382284
Taxes Payable Current13821114715293211939782230110144
Liabilities Of Disposal Group Including Discontinued Operation-------2625---
Other Liabilities Current12512110799130117125115938910297
Liabilities Current2,0612,0532,2351,8073,3663,3853,4121,7021,7971,9091,8891,608
Long Term Debt Noncurrent9,0489,0459,0427,0695,2315,2275,2206,5746,5636,5626,5646,552
Deferred Income Tax Liabilities Net122130139147156161167172175136146160
Operating Lease Liability Noncurrent190193196204210173174181181184188191
Accrued Income Taxes Noncurrent288281276270265277272274267277271262
Other Liabilities Noncurrent220219248264274220222220222228237259
Liabilities11,92911,92112,1369,7619,5029,4439,4679,1239,2059,2969,2959,032
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
Common Stock Value555555555555
Treasury Stock Value-11,845-11,288-10,685-8,606-8,226-7,888-7,445-6,889-6,464-5,928-5,597-5,369
Additional Paid In Capital1,1311,1051,1011,2241,2031,1801,1821,1631,1461,1261,1331,116
Retained Earnings Accumulated Deficit14,65314,18313,74413,59312,87212,37511,96811,80611,12410,69610,29510,140
Accumulated Other Comprehensive Income Loss Net Of Tax-796-772-834-818-877-1,017-940-851-845-841-839-814
Stockholders Equity3,1483,2333,3315,3985,1594,8654,7705,2344,9665,0524,9975,078
Minority Interest00000000-6-6-6-4
Liabilities And Stockholders Equity15,07715,15415,46715,15914,47914,09814,23714,35714,16514,34814,28614,106
Preferred Stock Shares Authorized----------1,000-
Allowance For Doubtful Accounts Receivable Current141916181719181922201818
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment3,0663,0022,9252,8722,7962,6972,6352,6572,5902,6732,5942,529
Common Stock Par Or Stated Value Per Share0.010.010.010.010.010.010.010.010.010.010.010.01
Common Stock Shares Authorized6,0006,0006,0006,0006,0006,0006,0006,0006,0006,0006,0006,000
Common Stock Shares Issued502502502502502502502502502502502502
Shares Outstanding414420425441444446448452454457458460
Treasury Stock Common Shares888277605856535048454442
Restricted Cash Current312401241223

Select a line item above to chart it.

Recent filings

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial

Zoetis Inc. (ZTS) — SEC Financial Statements & Analysis

Zoetis Inc. (ZTS) is a pharmaceutical preparations company. Zoetis Inc. trades on NYSE as: ZTS. Zoetis Inc. (ZTS)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-06. Based on that filing, Zoetis Inc. carries a market cap of $29.80B, a P/E ratio of 11.30x, a P/B ratio of 9.47x, a P/S ratio of 3.13x, an enterprise value of $37.37B, and an EV/EBITDA multiple of 9.30x. On profitability, it posts a gross margin of 71.67%, an operating margin of 34.64%, a net margin of 27.69%, a Return on Equity (ROE) of 63.49%, a Return on Assets (ROA) of 17.84%, and a Return on Invested Capital (ROIC) of 26.66%. Per share, it reports EPS of $6.31, diluted EPS of $6.31, free cash flow per share of $5.55, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 1.58% year-over-year, net income growth of 1.38% year-over-year, and EPS growth of 8.06% year-over-year. On the balance sheet, it maintains a current ratio of 3.08x, a quick ratio of 1.84x, working capital of $4.29B, a debt-to-equity ratio of 3.79x, a debt ratio of 0.79, an interest coverage ratio of 14.86x, free cash flow of $2.32B (TTM), and net debt of $7.57B. Figures sourced from SEC EDGAR.

Market Cap
$29.80B
P/E TTM
11.30x
EPS TTM
$6.31
P/B TTM
9.47x
ROE TTM
63.49%
ROA TTM
17.84%
Debt To Equity
3.79x
Free Cash Flow TTM
$2.32B
Net Revenue TTM Growth 1Y
1.58%

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Zoetis Inc. in?

Zoetis Inc. (ZTS) operates in the Pharmaceutical Preparations industry.

What exchange does ZTS trade on?

Zoetis Inc. (ZTS) trades on the NYSE.

When was Zoetis Inc. (ZTS)'s most recent SEC filing?

Zoetis Inc. (ZTS)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-06.

What is ZTS's market cap?

Zoetis Inc. (ZTS) has a market capitalization of $29.80B as of 2026-06-30.

What is ZTS's P/E ratio?

Zoetis Inc. (ZTS)'s trailing twelve month P/E ratio is 11.30x as of 2026-06-30.

What is ZTS's EPS (earnings per share)?

Zoetis Inc. (ZTS)'s trailing twelve month EPS is $6.31 as of 2026-06-30.

What is ZTS's ROE (return on equity)?

Zoetis Inc. (ZTS)'s trailing twelve month Return on Equity (ROE) is 63.49% as of 2026-06-30.

What is ZTS's ROA (return on assets)?

Zoetis Inc. (ZTS)'s trailing twelve month Return on Assets (ROA) is 17.84% as of 2026-06-30.

What is ZTS's ROIC (return on invested capital)?

Zoetis Inc. (ZTS)'s trailing twelve month Return on Invested Capital (ROIC) is 26.66% as of 2026-06-30.

What is ZTS's EV/EBITDA?

Zoetis Inc. (ZTS)'s trailing twelve month EV/EBITDA is 9.30x as of 2026-06-30.

Wall Street's data.
Main Street's price.

Start 7-day free trial